Loading…
for educational and safety purposes
RAD-140 and LGD-4033 both come up in the same conversations; they overlap on Muscle Growth and Testosterone. RAD-140: RAD-140, also known as testolone, is an experimental selective androgen receptor modulator, or SARM, a class of nonsteroidal compounds designed to stimulate muscle and bone growth while causing fewer of the unwanted effects of anabolic steroids. LGD-4033: LGD-4033, also known as ligandrol or VK5211, is an investigational nonsteroidal selective androgen receptor modulator, a class of compounds abbreviated as SARM.
RAD-140, also known as testolone, is an experimental selective androgen receptor modulator, or SARM, a class of nonsteroidal compounds designed to stimulate muscle and bone growth while causing fewer of the unwanted effects of anabolic steroids. It was created by a pharmaceutical company as a potential treatment for conditions such as muscle wasting and, later, hormone-sensitive breast cancer, but it has not been approved for any medical use. Despite this, it is sold online and misused for bodybuilding, a practice associated with reports of liver and heart injury, and it is banned in sport by anti-doping authorities.
LGD-4033, also known as ligandrol or VK5211, is an investigational nonsteroidal selective androgen receptor modulator, a class of compounds abbreviated as SARM. It binds the androgen receptor, the same target acted on by testosterone, but is designed to stimulate muscle and bone while having weaker effects on other tissues. First described by Ligand Pharmaceuticals and later developed by Viking Therapeutics, it has been studied for muscle wasting but is not approved for any medical use, and it is banned in sport and sold illicitly to bodybuilders.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
selective agonist (SARM)
Selective tissue-preferential agonist
stresses (risk)
weak agonist
Dose-dependent suppression of endogenous testosterone
Lowers HDL and SHBG dose-dependently
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.